Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.
about
Cytomegalovirus-induced immunopathology and its clinical consequencesAntiviral medications for preventing cytomegalovirus disease in solid organ transplant recipientsProgress and problems in understanding and managing primary Epstein-Barr virus infectionsCytomegalovirus Hyper Immunoglobulin for CMV Prophylaxis in Thoracic TransplantationCytomegalovirus infection in transplant recipientsHuman CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigmCytomegalovirus infection in immunocompetent critically ill adults: literature reviewRisk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control studyValganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacyCytomegalovirus: pathogen, paradigm, and puzzleHematologic complications of anti-CMV therapy in solid organ transplant recipients.Six-month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infection.Management of cytomegalovirus infection and disease in liver transplant recipients.Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.Current concepts on cytomegalovirus infection after liver transplantationPost-transplant infections: An ounce of prevention.Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.IMPACT trial results should not change current standard of care of 100 days for cytomegalovirus prophylaxis.Preemptive therapy prevents cytomegalovirus end-organ disease in treatment-naïve patients with advanced HIV-1 infection in the HAART era.Opportunistic infections--coming to the limits of immunosuppression?Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected womenDynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipientsLong-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patientsAntiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy.The case for cytomegalovirus prophylaxis in solid organ transplantation.Need for quality improvement in renal systematic reviews.Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.Cytomegalovirus in transplantation - challenging the status quo.Sepsis and cytomegalovirus: foes or conspirators?Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences.Viral lower urinary tract infections.Gastrointestinal cytomegalovirus disease in the immunocompromised patient.Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review.Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients.Cytomegalovirus infections in solid organ transplantation: a review.Cytomegalovirus reactivation in critically ill immunocompetent patients.Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?Cytomegalovirus infection in critically ill patients: a systematic review.
P2860
Q21195897-FED3868B-25AC-41E6-93BA-9D1590E03A35Q24200697-5C6A186E-E9F4-46F4-A3C0-A9A42A55C431Q24597706-71D5559B-C921-4A3C-B5C8-6EECF7E5F2AFQ26768477-58219D35-513D-423B-8521-2AB476200CD8Q26801802-EC2A1D57-D83B-49CE-AA01-433A46191CB6Q26850340-DD3719BE-F8C5-4A70-99DD-C96AEC317E9BQ28079509-AB45036A-B38E-4F17-A3C8-179BB0B50773Q28298477-C82FCAD7-7587-4236-88DB-F673D484B83CQ28475480-961E246A-1F6B-42B4-AC32-7408B708175EQ33351523-71840E63-43FE-4D07-9BF5-C5B7D13623F0Q33383116-E3455514-9700-4BEA-8475-FF6C6235D97AQ33561715-BE8A7742-A44A-4C38-9765-83EF3086947DQ33845124-91D78EDF-1202-4C29-B9EA-0A8DC933CEDDQ34294806-CEABADE1-D0BC-4E7D-82E1-7E6C84520268Q34390310-30549F9B-72D1-4925-A9EF-820EE529DDF8Q34435191-CF8FED62-B05C-4709-BCC5-397FCA25E3D9Q34613091-745C2724-B867-4E3A-8BED-B55CEA349051Q34690629-B5B5EAAA-F682-4DDD-8CC3-9645F757ACBAQ34750093-6FAF3AC8-76B1-4E23-9E79-AC5D0F480DD6Q35004372-607FF42D-E211-49FB-85BA-087AC4C96846Q35051236-7377EDAF-D3A6-4037-8821-4538A695BA8BQ35087763-E399BCBF-6BAE-4F5B-A3F6-42F2444EBEDCQ35544428-1C5B9161-636C-464C-9961-29583613E9CFQ36200933-1307AA23-80F1-4E67-B0AF-62F9D7E01E70Q36321541-67510FA2-F2D1-4C04-B906-5515107771C5Q36551556-9585226A-24A1-41DB-80E4-E7C9271F8334Q36556542-7487F36A-A5B8-4B91-AB74-9F93175D5D9CQ36736617-F2FF1726-A5E7-4349-869B-A8A9250D5FF8Q36759073-CD959646-F4BF-4D93-B74E-BA23101BB502Q36787493-0D0FCD69-CD5A-4FA0-9059-30C57AE7F340Q37055722-39CEB657-C520-4EDD-BC97-003443250E73Q37065216-452843B4-0E3B-4ECE-9E71-4C709040F61AQ37179609-C608D7A4-C5F7-47DE-A8E2-F1C13358982BQ37216870-9C38CB24-2FE7-480E-B78D-C61E8CDC130CQ37283970-8DE62C60-DAB9-4DE1-9459-6CC63AD26719Q37318303-CD32EAAD-C496-44C1-B212-28DAA89D5CFCQ37359332-A7D4331A-EB78-4396-B07A-9D542323324BQ37414600-70A590D3-56C1-4421-BA21-AAEF7B2B82FCQ37453850-A448E286-25C2-4413-8527-1514648D2338Q37482179-FF40C5D2-5CA3-4C16-B7B4-1455EDFA463C
P2860
Meta-analysis: the efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Meta-analysis: the efficacy of ...... d organ transplant recipients.
@en
Meta-analysis: the efficacy of ...... d organ transplant recipients.
@nl
type
label
Meta-analysis: the efficacy of ...... d organ transplant recipients.
@en
Meta-analysis: the efficacy of ...... d organ transplant recipients.
@nl
prefLabel
Meta-analysis: the efficacy of ...... d organ transplant recipients.
@en
Meta-analysis: the efficacy of ...... d organ transplant recipients.
@nl
P2093
P1476
Meta-analysis: the efficacy of ...... d organ transplant recipients.
@en
P2093
Alison G Freifeld
Andre C Kalil
Elizabeth Lyden
Josh Levitsky
Julie Stoner
P304
P356
10.7326/0003-4819-143-12-200512200-00005
P407
P577
2005-12-01T00:00:00Z